In the HCC samples, CD4 and CD8 T cells were observed in the tumor parenchyma and tumor stroma (Fig. 1A and B), and the intensity of CD4 or CD8 immunoreactivity was homogeneous in all samples examined. The gene discussed is CD8A; the disease is neoplasm.